The effects of acarbose treatment on cardiovascular risk factors in impaired glucose tolerance and diabetic patients: a systematic review and dose–response meta-analysis of randomized clinical trials

Acarbose (ACB) seems to be an effective drug in the management of cardiovascular risk factors. However, no previous meta-analysis of randomized controlled trials (RCTs) has been done to evaluate the effects of ACB on cardiovascular risk factors on impaired glucose tolerance (IGT), type 2 diabetes me...

Descripción completa

Detalles Bibliográficos
Autores principales: Zamani, Mohammad, Nikbaf-Shandiz, Mahlagha, Aali, Yasaman, Rasaei, Niloufar, Zarei, Mahtab, Shiraseb, Farideh, Asbaghi, Omid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433190/
https://www.ncbi.nlm.nih.gov/pubmed/37599681
http://dx.doi.org/10.3389/fnut.2023.1084084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433190/
https://www.ncbi.nlm.nih.gov/pubmed/37599681
http://dx.doi.org/10.3389/fnut.2023.1084084

Ejemplares similares